PhysiologybioRxivPreprint
Adropin protects against cardiac remodeling and metabolic dysfunction in a mouse model of HFpEF
Bellina A.S. Mushala, Michael Wayne Stoner, Maryam Sharifi‐Sanjani…·Iain Scott
This study shows Adropin treatment reverses cardiac dysfunction and metabolic defects in a mouse model of HFpEF by reducing O-GlcNAcylation of LCAD and improving fatty acid oxidation.
3 citations